ADVFN

rikky72 05/11/2024 07:57 Read Full Thread Reply I would prefer it to be a £90 billion company.. :) Read Full Thread Reply
pierre oreilly 01/11/2024 10:07 Read Full Thread Reply Love to see the attempts at deramping (and ramping for that matter) a 60 billion company! But come on advfnets, buy 500 quids worth please. Read Full Thread Reply
supermarky 01/11/2024 10:01 Read Full Thread Reply For goodness sake Mr De-ramper, please calm down. I am sure none of us are going to panic sell due to your terrifying assessment. Halloween was yesterday. Read Full Thread Reply
dr biotech 01/11/2024 09:57 Read Full Thread Reply I added again yesterday at 13.73 which now seems well timed. Better than my larger purchase at 14.73 last month…large overseas earners would benefit from a weaker pound and a hedge against uk inflation Read Full Thread Reply
mister md 01/11/2024 09:34 Read Full Thread Reply Had some chunky dividends to re-invest somewhere, so decided to follow in Lady Susan Symonds footsteps and add to my GSK holding this morning - but not expecting any quick recovery here, FTSE/UK is very unloved at the moment! Read Full Thread Reply
tradermichael 31/10/2024 17:58 Read Full Thread Reply You're obviously deramping with your recent posts! ;0] Read Full Thread Reply
halfpenny 31/10/2024 15:50 Read Full Thread Reply Wait as 2025 news shock the market as more falls to come.... Too Risky at these levels.. Read Full Thread Reply
dope007 31/10/2024 15:44 Read Full Thread Reply Profits and sales rising so she ain't doing anything wrong Read Full Thread Reply
spoole5 31/10/2024 15:39 Read Full Thread Reply Wouldn't trust her to run my local boots pharmacy Read Full Thread Reply
halfpenny 31/10/2024 12:44 Read Full Thread Reply Emma W. cant be transferred as nobody wants her!! Looks like you are stuck with the CEO. Future bleak for 2025 she will remain to take the hit!! Read Full Thread Reply
halfpenny 31/10/2024 12:27 Read Full Thread Reply Never catch a Falling Knife and this one is sharp with more Issues as Costs since budget increase. Massive Issues Ahead in 2025... Read Full Thread Reply
alphorn 31/10/2024 11:47 Read Full Thread Reply The China issue hitting AZN again today. I wonder how 'clean' other pharmas are? (My post on AZN). Read Full Thread Reply
orlando42 31/10/2024 10:29 Read Full Thread Reply If Man Utd can get rid of Ten Hag why can’t GSK get rid of Emma Walmsley Read Full Thread Reply
halfpenny 31/10/2024 09:57 Read Full Thread Reply Everyone is marking them Down Down Down! Smart Investors target price 1000p How Soon How Low its a disaster!! Read Full Thread Reply
dplewis1 31/10/2024 09:39 Read Full Thread Reply Stifel cuts target to price to 1640p from 1770p Read Full Thread Reply
dplewis1 31/10/2024 09:36 Read Full Thread Reply JP Morgan cuts target price to 1440p from 1550p. Read Full Thread Reply
halfpenny 31/10/2024 09:27 Read Full Thread Reply "There is Trouble Ahead" With support level broken down the slippery slope continues with another leg down! down! down! Take a pill it may help! How Low How Soon !! Read Full Thread Reply
spoole5 31/10/2024 09:22 Read Full Thread Reply Pressure must be building on Emma. Overpromoted in the name of diversity Read Full Thread Reply
spoole5 31/10/2024 08:23 Read Full Thread Reply This will put on a pound with some proper leadership Read Full Thread Reply
supermarky 31/10/2024 08:11 Read Full Thread Reply just bought a few more to hold in my isa. Holding firm Buy and hold Read Full Thread Reply
pander45 30/10/2024 23:22 Read Full Thread Reply Not entirely sure it's the bottom Watford but just cant deny the value here now. Hope you bag some tomorrow! Read Full Thread Reply

Showing 33876 to 33896 of 34500 messages

IN BRIEF: GlaxoSmithKline seeks approval in US for use of Priorix

LC - FTSE 100-listed pharmaceutical company - Submits biologics license application to US Food & Drug Administration f ...

GlaxoSmithKline PLC Total Voting Rights

GlaxoSmithKline PLC 02 August 2021 GlaxoSmithKline plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's...

GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps

First IL-5 therapy approved as an add-on treatment in the US for adults with chronic rhinosinusitis with nasal polyps to target eosinophilic...

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

GlaxoSmithKline PLC Director/PDMR Shareholding

GlaxoSmithKline PLC 28 July 2021 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely...

GlaxoSmithKline 2Q Net Profit Fell Despite Higher Sales; Backs 2021 Outlook -- Update

By Cecilia Butini GlaxoSmithKline PLC said Wednesday that second-quarter net profit fell from the previous year, though sales grew, and backed its...

TOP NEWS: GSK retains guidance despite weaker interim results

GlaxoSmithKline PLC on Wednesday held its expectations for 2021 as a whole, in spite of a weaker performance for the ...

GlaxoSmithKline 2Q Net Profit Drops Despite Higher Sales; Backs 2021 Outlook

By Cecilia Butini GlaxoSmithKline PLC said Wednesday that net profit dropped in the second quarter compared with the previous year, though sales...

GlaxoSmithKline, Vir Biotechnology to Supply Covid-19 Treatment to European Commission

By Chris Wack GlaxoSmithKline PLC and Vir Biotechnology Inc. said they have signed a joint procurement agreement with the European Commission to...

EU Commission Signs Contract With GlaxoSmithKline for Supply of Covid-19 Drug

By Cecilia Butini The European Commission said Wednesday that it has signed a contract with GlaxoSmithKline PLC for the supply of a monoclonal...

GlaxoSmithKline PLC 2nd Quarter Results

GlaxoSmithKline PLC 28 July 2021 Issued: Wednesday, 28 July 2021, London U.K. GSK delivers strong Q2 sales of GBP8.1 billion, +6% AER, +15% CER...

GlaxoSmithKline PLC Director/PDMR Shareholding

GlaxoSmithKline PLC 26 July 2021 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely...

GlaxoSmithKline gets US Shingrix approval for immunocompromised adults

GlaxoSmithKline PLC on Monday said the US Food & Drug Administration has approved its Shingrix shingles prevention v ...

Company description

Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,477.50p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,945,481 shares in issue. The market capitalisation of Gsk is £61.26 billion. Gsk has a price to earnings ratio (PE ratio) of 23.93.

Type	Ordinary Share
Share ISIN	GB00BN7SWP63
Sector	Pharmaceutical Preparations
Bid Price	1,486.00
Offer Price	1,486.50
Open	1,478.00
Shares Traded	5,748,076
Last Trade	16:35:14

Low - High	1,476.50 - 1,491.00
Turnover	31.38B
Profit	2.58B
EPS - Basic	0.6211
PE Ratio	23.93
Market Cap	61.26B

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Gsk Plc (GSK)

IN BRIEF: GlaxoSmithKline seeks approval in US for use of Priorix

GlaxoSmithKline PLC Total Voting Rights

GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

GlaxoSmithKline PLC Director/PDMR Shareholding

GlaxoSmithKline 2Q Net Profit Fell Despite Higher Sales; Backs 2021 Outlook -- Update

TOP NEWS: GSK retains guidance despite weaker interim results

GlaxoSmithKline 2Q Net Profit Drops Despite Higher Sales; Backs 2021 Outlook

GlaxoSmithKline, Vir Biotechnology to Supply Covid-19 Treatment to European Commission

EU Commission Signs Contract With GlaxoSmithKline for Supply of Covid-19 Drug

GlaxoSmithKline PLC 2nd Quarter Results

GlaxoSmithKline PLC Director/PDMR Shareholding

GlaxoSmithKline gets US Shingrix approval for immunocompromised adults

Your Recent History

Pivozon Boosts Gold Trading On D1 Timeframe

US Lawmakers Warn Trump: Ditch Crypto Before It Harms America

London open: FTSE 100 Stocks steady as investors mull retail sale...

Ecora Resources Price: ECOR Holds Downward, Attempting a Re-base

FxSpire: False-Breakout Detection Software Uses AI To Aid EUR/USD...

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Gsk Plc (GSK) Share Chat

Gsk Plc (GSK)

Discussion Insights

News Insights

Gsk Share Discussion Threads

News

IN BRIEF: GlaxoSmithKline seeks approval in US for use of Priorix

GlaxoSmithKline PLC Total Voting Rights

GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

GlaxoSmithKline PLC Director/PDMR Shareholding

GlaxoSmithKline 2Q Net Profit Fell Despite Higher Sales; Backs 2021 Outlook -- Update

TOP NEWS: GSK retains guidance despite weaker interim results

GlaxoSmithKline 2Q Net Profit Drops Despite Higher Sales; Backs 2021 Outlook

GlaxoSmithKline, Vir Biotechnology to Supply Covid-19 Treatment to European Commission

EU Commission Signs Contract With GlaxoSmithKline for Supply of Covid-19 Drug

GlaxoSmithKline PLC 2nd Quarter Results

GlaxoSmithKline PLC Director/PDMR Shareholding

GlaxoSmithKline gets US Shingrix approval for immunocompromised adults

Company description

Your Recent History

Pivozon Boosts Gold Trading On D1 Timeframe

US Lawmakers Warn Trump: Ditch Crypto Before It Harms America

London open: FTSE 100 Stocks steady as investors mull retail sale...

Ecora Resources Price: ECOR Holds Downward, Attempting a Re-base

FxSpire: False-Breakout Detection Software Uses AI To Aid EUR/USD...

Company

Business

Popular

Get The App

Go Ad-Free